{"mainPropery":{"diseaseId":9450,"diseaseName":"Gigantomastia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9450/gigantomastia","synonyms":["Macromastia","Gestational gigantomastia (subtype)","Pregnancy-induced gigantomastia (subtype)","Idiopathic gigantomastia (subtype)","Puberty-induced gigantomastia (subtype)","Juvenile gigantomastia (subtype)","Drug-induced gigantomastia (subtype)","Medication-induced gigantomastia (subtype)"],"synonyms-with-source":[{"name":"Macromastia"},{"name":"Gestational gigantomastia (subtype)"},{"name":"Pregnancy-induced gigantomastia (subtype)"},{"name":"Idiopathic gigantomastia (subtype)"},{"name":"Puberty-induced gigantomastia (subtype)"},{"name":"Juvenile gigantomastia (subtype)"},{"name":"Drug-induced gigantomastia (subtype)"},{"name":"Medication-induced gigantomastia (subtype)"}],"identifiers":[{"identifierType":"OMIM","identifierId":"113670"},{"identifierType":"ORPHANET","identifierId":"180176"}]},"diseaseCategories":[],"organizations":[{"resourceID":442,"resourceName":"La Leche League International","address1":"P.O. Box 4079","address2":"","address3":"","address4":"","address5":"","city":"Schaumburg","state":"IL","zip":"60168-4079 ","country":"United States","phone":"847-519-7730 ","tty":"847-592-7570 ","tollFree":"800-LALECHE (525-3243) ","fax":"847-969-0460 ","email":"http://www.llli.org/contact/contact_us","url":"http://www.llli.org"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/113670' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=Gigantomastia%5BAll%20Fields%5D%20AND%20hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Gigantomastia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Gigantomastia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Gigantomastia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=180176' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/phenotype/HP:0010313' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2172,"questionText":"What is gigantomastia?","answerText":"<strong>Gigantomastia</strong> is a rare condition characterized by excessive breast growth. It may occur spontaneously, during puberty or pregnancy, or while taking certain medications.[1333][1335] There is no universally&nbsp;accepted definition of gigantomastia, but the majority of medical articles&nbsp;refer to a particular weight of excess breast&nbsp;tissue.[12316] Symptoms of gigantomastic may include mastalgia (breast pain), ulceration/infection, posture problems, back pain and chronic traction injury to 4th/5th/6th intercostal nerves with resultant loss of nipple sensation. It is also associated with decreased fetal growth, if it occurs during pregnancy.[1333]<br />\r\n<br />\r\nThe exact cause of gigantomastia is not known; however, hormonal and hereditary factors may be involved. Additionally, gigantomastia has been noted as a side effect of treatment with certain medications, such as like D-penicillamine.[1334][1335] Treatment may include breast reduction, mastectomy with or without reconstruction, hormonal treatment, or a combination of treatments.[1333][1334]","dateModified":"2016-10-05T00:00:00"},"basicQuestions":[{"questionId":2173,"questionText":"How might gigantomastia be treated?&nbsp;","answerText":"Breast reduction with or without hormonal therapy is often the first line of treatment for women who have gigantomastia. However, recurrence of&nbsp;gigantomastia&nbsp;may occur, requiring a second breast reduction procedure or mastectomy. Mastectomy might be recommended following recurrence of gigantomastia after breast reduction, especially in those&nbsp;patients who have&nbsp; gigantomastia associated with puberty or pregnancy.[1333]&nbsp; It is important to discuss this information with a health care provider in order to determine what treatment might be appropriate.","dateModified":"2016-10-05T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1333,"authors":"Dancey A, Khan M, Dawson J, Peart F","articleTitle":"Gigantomastia - a classification and review of the literature","bookWebsiteJournalTitle":"J Plast Reconstr Aesthet Surg","date":"December 13, 2007","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/18054304","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":24053,"abbreviatedInquiry":"My wife had a breast reduction to cure gigantomastia. But after a year, the ailment recurred.&nbsp; What treatment options might be available for her now?","caseQuestions":[{"questionId":2172,"questionText":"What is gigantomastia?","answerText":"<strong>Gigantomastia</strong> is a rare condition characterized by excessive breast growth. It may occur spontaneously, during puberty or pregnancy, or while taking certain medications.[1333][1335] There is no universally&nbsp;accepted definition of gigantomastia, but the majority of medical articles&nbsp;refer to a particular weight of excess breast&nbsp;tissue.[12316] Symptoms of gigantomastic may include mastalgia (breast pain), ulceration/infection, posture problems, back pain and chronic traction injury to 4th/5th/6th intercostal nerves with resultant loss of nipple sensation. It is also associated with decreased fetal growth, if it occurs during pregnancy.[1333]<br />\r\n<br />\r\nThe exact cause of gigantomastia is not known; however, hormonal and hereditary factors may be involved. Additionally, gigantomastia has been noted as a side effect of treatment with certain medications, such as like D-penicillamine.[1334][1335] Treatment may include breast reduction, mastectomy with or without reconstruction, hormonal treatment, or a combination of treatments.[1333][1334]","dateModified":"2016-10-05T00:00:00","references":[{"referenceId":1333,"authors":"Dancey A, Khan M, Dawson J, Peart F","articleTitle":"Gigantomastia - a classification and review of the literature","bookWebsiteJournalTitle":"J Plast Reconstr Aesthet Surg","date":"December 13, 2007","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/18054304","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1334,"authors":"Antevski BM, Smilevski DA, Stojovski MZ, Filipovski VA, Banev SG","articleTitle":"Extreme gigantomastia in pregnancy:  case report and review of literature","bookWebsiteJournalTitle":"Arch Gynecol Obstet","date":"2007"},{"referenceId":1335,"authors":"Kulkarni D, Beechey-Newman N, Hamed H, Fentiman IS","articleTitle":"Gigantomastia: A problem of local recurrence","bookWebsiteJournalTitle":"The Breast","date":"2006"},{"referenceId":12316,"authors":"H. Dafydd, K.R. Roehl, L.G. Phillips, A. Dancey, F. Peart, K. Shokrollahi","articleTitle":"Redefining gigantomastia","bookWebsiteJournalTitle":"Journal of Plastic, Reconstructive & Aesthetic Surgery","date":"2011","volume":"64","pages":"160-163","url":"https://www.ncbi.nlm.nih.gov/pubmed/20965141","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2173,"questionText":"How might gigantomastia be treated?&nbsp;","answerText":"Breast reduction with or without hormonal therapy is often the first line of treatment for women who have gigantomastia. However, recurrence of&nbsp;gigantomastia&nbsp;may occur, requiring a second breast reduction procedure or mastectomy. Mastectomy might be recommended following recurrence of gigantomastia after breast reduction, especially in those&nbsp;patients who have&nbsp; gigantomastia associated with puberty or pregnancy.[1333]&nbsp; It is important to discuss this information with a health care provider in order to determine what treatment might be appropriate.","dateModified":"2016-10-05T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1333,"authors":"Dancey A, Khan M, Dawson J, Peart F","articleTitle":"Gigantomastia - a classification and review of the literature","bookWebsiteJournalTitle":"J Plast Reconstr Aesthet Surg","date":"December 13, 2007","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/18054304","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14149,"phenoTypeName":"Abnormal thorax morphology","percentRanges":"-"},{"phenoTypeId":10458,"phenoTypeName":"Sex-limited autosomal dominant","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Gigantomastia"}